Dose Selection for DuoBody®-CD40x4-1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data
利用临床前和临床数据，采用 mPBPK/RO 模型选择 DuoBody®-CD40x4-1BB (GEN1042/BNT312) 的剂量
期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3677
Bajaj, Gaurav; Shchelokov, Dmitry; Demin, Oleg Jr; Adams, Homer C 3rd; Feng, Yan; Gibiansky, Leonid; van der Lee, Saskia; Johri, Anandhi; Belete, Merzu; Muik, Alexander; Panorchan, Porntula; Türeci, Özlem; Sahin, Uğur; Ahmadi, Tahamtan; Gupta, Manish; Demin, Oleg; Thalhauser, Craig
